CD44 and lip and oral cavity carcinoma: A recent study showed that OCSC-derived small EVs from CD133+ CD44+ oral cancer cells transport the lncRNA UCA1, which binds to miR-134, thus modulating the PI3K/AKT pathway through LAMC2.